VALDECOXIB 10MG-ORAL, Bextra
NOTE: April 7, 2005, Pfizer agreed to suspend sales and marketing of Bextra in the U.S., pending further discussions with the with the FDA. For more information, please read the FDA press release.
GENERIC NAME: VALDECOXIB 10MG - ORAL (val-deh-COX-ib)
BRAND NAME(S): Bextra
WARNING: Rarely, serious (possibly fatal) allergic reactions have occurred with valdecoxib, including skin reactions. Seek immediate medical attention if an allergic reaction occurs. Symptoms of an allergic reaction may include: rash, mouth sores, itching, swelling, dizziness, trouble breathing.
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!